Evidence map›Paper›PMID 41696826›Full record

ReviewJournal of mass spectrometry : JMS2026

Advances in Mass Spectrometry Instrumentation and Methodology for Analysis of Alternative Protein Isoforms.

Micah D Lehe, Raghad Almofeez, Erin D Jeffery, Gloria M Sheynkman

Abstract readReview
In one paragraph

Review in Journal of mass spectrometry : JMS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Micah D LeheDepartment of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, USA.ORCID https://orcid.org/0000-0002-3219-6066
Raghad AlmofeezDepartment of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, USA.ORCID https://orcid.org/0009-0006-8553-9073
Erin D JefferyDepartment of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, USA.
Gloria M SheynkmanDepartment of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, USA.

Funding

Biotechnology Training ProgramT32GM136615 · NIGMS · UNIVERSITY OF VIRGINIA · PI Silvia Salinas Blemker, Kimberly A. Kelly · 2020 to 2026
$3.4M
Uncovering the functional diversification mechanisms of transcription factor isoforms involved in stem cell differentiationR35GM142647 · NIGMS · UNIVERSITY OF VIRGINIA · PI SHEYNKMAN, GLORIA · 2021 to 2025
$2.1M
IMAT-ITCR Collaboration: A Cytoscape Toolkit to Model Proteoform-Resolved Cancer NetworksR33CA281919 · NCI · UNIVERSITY OF VIRGINIA · PI Gloria Sheynkman · 2024 to 2026
$1.3M
NCI NIH HHS R33 CA281919NIGMS NIH HHS 2T32GM136615-06NIGMS NIH HHS R35 GM142647NIGMS NIH HHS R35GM142647NIGMS NIH HHS T32 GM136615
6 · The paper itself

Abstract

Proteoforms represent the many final protein products that can be generated by a protein-coding gene. A key source of proteomic variation is alternative splicing (AS), with at least 90% of human genes undergoing AS to cause protein sequence alterations that impact protein structure and function. Therefore, detection and characterization of the protein isoforms generated by splicing is critical to a complete understanding of the effects of splicing on human phenotype and disease. Advancements in the power and throughput of mass spectrometry (MS) instrumentation over the past decade, coupled with growing interest in splicing among the proteomics community, are driving a new wave of MS utilization for protein isoform analysis. In this review, we outline recent innovations in MS instruments and the new acquisition strategies they support, sample preparation protocols, and integrative bioinformatics pipelines that have enabled deeper sampling of the alternative proteome. We highlight research from the field utilizing bottom-up and top-down MS as well as discovery and targeted acquisition methods, outlining the isoform coverage and advantages offered by each approach. Based on the evolution of the field, splicing continues to garner greater attention within the context of proteoform diversity.

Indexed as

Mass SpectrometryProteomicsAlternative SplicingAnimalsHumansProtein IsoformsProtein Isoforms

Identifiers

PMID41696826
PMCPMC12912779

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.